TY  - JOUR 
AU  - Muntión Olave, Sandra
AU  - Preciado Pérez, Silvia
AU  - Sánchez Luis, Elena
AU  - Corchete Sánchez, Luis Antonio
AU  - Díez-Campelo, María
AU  - Osugui, Lika
AU  - Martí Chillón, Gerardo Javier
AU  - Vidriales Vicente, María Belén
AU  - Navarro Bailón, Almudena
AU  - Rivas Sanz, Javier de las
AU  - Sánchez Guijo Martín, Fermín
PY  - 2022
SN  - 2040-6207
UR  - http://hdl.handle.net/10366/161402
AB  - [EN]Background: Eltrombopag (EP) is a small molecule that acts directly on hematopoietic stem cells (HSCs) and megakaryocytes to stimulate the hematopoietic process. Mesenchymal stem/ stromal cells (MSCs) are key hematopoietic niche...
LA  - eng
PB  - Sage Journals
KW  - Aplasia, Eltrombopag, Hematopoiesis, Mesenchymal stem cells, MSC
KW  - Aplasia
KW  - Eltrombopag
KW  - Hematopoiesis
KW  - Mesenchymal stem cells
KW  - Receptors, Thrombopoietin
KW  - Anemia, Aplastic
KW  - Mesenchymal Stromal Cells
KW  - Hematopoiesis
TI  - Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
DO  - 10.1177/20406207221142137
T2  - Therapeutic Advances in Hematology
VL  - 13
M2  - 1
ER  -